Forschungsintensive Industrien wie die Biotechnologie sind geprägt von einer Vielzahl an Kooperationen zwischen etablierten Großunternehmen mit kleinen Partnern. Aber die Misserfolgsraten solcher Vereinbarungen sind trotz einer zunehmenden Kooperationserfahrung der beteiligten Unternehmen...

This paper analyses a large database on inter-firm R&D cooperation formed in the pharmaceutical biotechnology industry during the period 1985 - 1998. The results indicate that network size largely grows, whereas the density of the network declines during the periods. In the network analysis that...

Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...